Concomitant Treatment with Etanercept and Tacrolimus Synergistically Attenuates Arthritis Progression via Inhibition of Matrix Metalloproteinase-3 Production and Osteoclastogenesis in Human TNF-α Transgenic Mice
In the present study, we investigated the effects and mechanisms of action of a combined treatment with etanercept, a soluble tumor necrosis factor receptor (p75) Fc fusion protein, and tacrolimus, a calcineurin inhibitor on the progression of arthritis in human tumor necrosis factor-α (TNF-α) trans...
Main Authors: | Iwao Seki, Miwa Takai-Imamura, Tomomi Kohara-Tanaka, Satoshi Shirae, Minoru Sasano, Hiroaki Matsuno, Hiroyuki Aono |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2019-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2019/4176974 |
Similar Items
-
Dynamics of concomitant therapy in children with juvenile idiopathic arthritis treated with etanercept and methotrexate
by: Ekaterina Alexeeva, et al.
Published: (2019-10-01) -
Fanconi Syndrome Induced by Concomitant HIV PrEP and Tacrolimus
by: Becky S. Linn PharmD, et al.
Published: (2021-10-01) -
Mapping the certolizumab pegol epitope on TNF and comparison with infliximab, adalimumab and etanercept
by: Henry Alistair I, et al.
Published: (2011-11-01) -
Intrinsic Restriction of TNF-Mediated Inflammatory Osteoclastogenesis and Bone Resorption
by: Baohong Zhao, et al.
Published: (2020-10-01) -
The Role of TNF-α in Morphine Tolerance: Effect of TNF-α inhibitor Etanercept and its therapeutic implication
by: Shen, Ching-Hui, et al.
Published: (2011)